inflammatory lesion

Vyome Therapeutics Begins Dosing in Phase2Trial of VB-1953 in Moderate to Severe Inflammatory Acne Vulgaris

New Delhi, April 25, 2019: Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases…

5 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420